A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats (Q43651464)

25 November 2017

A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats (English)

1 reference

25 November 2017

Zhu CZ

1

1 reference

25 November 2017

Mikusa J

2

1 reference

25 November 2017

Chu KL

3

1 reference

25 November 2017

Cowart M

4

1 reference

25 November 2017

Kowaluk EA

5

1 reference

25 November 2017

Jarvis MF

6

1 reference

25 November 2017

McGaraughty S

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

905

1 reference

25 November 2017

1-2

1 reference

25 November 2017

104-110

1 reference

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Pain assessment and evaluation of patients who have neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

The cardiac effects of adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Prevention and treatment of the complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: Pharmacological activities and potent inhibition of adenosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Efficient analysis of experimental observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Adenosine kinase inhibitors augment release of adenosine from spinal cord slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Adenosine receptor activation and nociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Adenosine release may mediate spinal analgesia by morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

Chronic catheterization of the spinal subarachnoid space.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902512-4

10.1016/S0006-8993(01)02512-4

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference